drugset / Trial / NCT02835404

Pelvic External Combined With 252-Cf Neutron Intracavitary Radiotherapy With or Without Platinum in Treating Advanced Cervical Cancer

NCT02835404

RandomizedParallel-groupOpen-labelTreatment

Summary

The objective of this study was to evaluate the efficacy and complication of the treatment of pelvic external combined with 252-Cf neutron intracavitary radiotherapy with or without platinum in local advanced cervical cancer patients in the short and long term.

Timeline

Start
2012-11
Primary completion
2017-06
Completion
2018-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Nedaplatin Small molecule 30 mg/m2 Intravenous
Subject Nedaplatin Small molecule 40 mg/m2 Intravenous

Indications